Nathalia Silva Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nathalia Silva Oliveira has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Luana Lorena Silva Rodrigues
Laboratório de Aids e Imunologia Molecular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
5 shared publications - Alcina Frederica Nicol
Laboratório Interdisciplinar de Pesquisas Médicas, Fiocruz, Instituto Oswaldo Cruz, Rio de Janeiro, RJ, Brasil
4 shared publications - Cecília Vianna de Andrade
Affiliation Laboratory of Pathology and Cytopathology, Fernandes Figueira National Institute of Women, Child, and Adolescent Health of Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil
4 shared publications - Wm Kast
Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, California
4 shared publications Alcina F. Nicol
Instituto Nacional de Infectologia Evandro Chagas, INI-FIOCRUZ, Rio de Janeiro, Brazil; Laboratório Interdisciplinar de Pesquisas Médicas, IOC-FIOCRUZ, Rio de Janeiro, Brazil
3 shared publications- Anna Karoline Fausto da Silva
Department of Pathology, Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, RJ, Brazil
3 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (11) , 216
Multiple Extraintestinal Malignancies and HPV16-Associated Neoplasms in Crohn’s Disease Under Prolonged Immunosuppression: A Case Report
Background: Crohn’s disease (CD) is a chronic inflammatory disease of the gastrointestinal tract with an increased risk for malignancy, particularly in patients undergoing immunosuppressive therapy. Case Presentation: This report describes the 23-year clinical course of a 20-year-old woman diagnosed with CD who, under prolonged therapy with azathioprine (AZA), developed three distinct carcinomas. The patient sequentially developed low-grade cervical intraepithelial neoplasia (CIN 1; Year 10; 3 years of AZA), a conjunctival squamous cell carcinoma (Year 14; 7 years of AZA; followed by a 10-month AZA pause), and a cutaneous basal cell carcinoma (Year 17; ~9.2 cumulative years of AZA). After CD recurrence and AZA resumption, CIN 2 was detected (Year 18; ~10.2 cumulative years of AZA). In the 18th year, AZA therapy was discontinued. Within less than one year (Year 19), cervical squamous cell carcinoma was diagnosed. In Year 23, CD was controlled, without neoplasms documented. High-risk HPV16 DNA was detected in cervical and conjunctival malignancies by PCR and confirmed by Sanger sequencing. Immunohistochemical analysis showed high Ki-67 and p16 expression and CD4+ cell predominance, supporting an association of HPV16 in these neoplasms. The short interval between CIN 2 and invasive CSCC detection is unusual. While this coincided with chronic immunosuppression, direct causality currently cannot be inferred; however, the patient’s chronic immune dysregulation and immunosuppression may be contributing factors. Conclusions: This case highlights the temporal co-occurrence of Crohn’s disease, prolonged immunosuppression, and HPV16 infection. These findings raise the need for vigilant extraintestinal cancer surveillance, regular screening, and HPV vaccination during chronic immunosuppression.
- 18 November 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (11) , 216
Open AccessMultiple Extraintestinal Malignancies and HPV16-Associated Neoplasms in Crohn’s Disease Under Prolonged Immunosuppression: A Case Report
Background: Crohn’s disease (CD) is a chronic inflammatory disease of the gastrointestinal tract with an increased risk for malignancy, particularly in patients undergoing immunosuppressive therapy. Case Presentation: This report describes the 23-year clinical course of a 20-year-old woman diagnosed with CD who, under prolonged therapy with azathioprine (AZA), developed three distinct carcinomas. The patient sequentially developed low-grade cervical intraepithelial neoplasia (CIN 1; Year 10; 3 years of AZA), a conjunctival squamous cell carcinoma (Year 14; 7 years of AZA; followed by a 10-month AZA pause), and a cutaneous basal cell carcinoma (Year 17; ~9.2 cumulative years of AZA). After CD recurrence and AZA resumption, CIN 2 was detected (Year 18; ~10.2 cumulative years of AZA). In the 18th year, AZA therapy was discontinued. Within less than one year (Year 19), cervical squamous cell carcinoma was diagnosed. In Year 23, CD was controlled, without neoplasms documented. High-risk HPV16 DNA was detected in cervical and conjunctival malignancies by PCR and confirmed by Sanger sequencing. Immunohistochemical analysis showed high Ki-67 and p16 expression and CD4+ cell predominance, supporting an association of HPV16 in these neoplasms. The short interval between CIN 2 and invasive CSCC detection is unusual. While this coincided with chronic immunosuppression, direct causality currently cannot be inferred; however, the patient’s chronic immune dysregulation and immunosuppression may be contributing factors. Conclusions: This case highlights the temporal co-occurrence of Crohn’s disease, prolonged immunosuppression, and HPV16 infection. These findings raise the need for vigilant extraintestinal cancer surveillance, regular screening, and HPV vaccination during chronic immunosuppression.
- Open Access
- 16 April 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (4) , e70909
Beyond Human Papillomavirus (HPV): Detection of EBV and Polyomaviruses in Cervical and Anal Samples
Colorectal and cervical cancers represent an important public health problem worldwide, particularly in Brazil. Colorectal cancer is one of the most frequently diagnosed malignancies worldwide and the most common cancer in both men and woman in Brazil. Although cervical cancer also remains a significant public health concern in the female population due to its high incidence and mortality rates. Epstein‐Barr virus (EBV), and Polyomaviruses (JCPyV and BKPyV) are considered as oncoviruses with a prevalence of 90% in the adult population. Studies suggest that coinfection with Human papillomavirus (HPV) and EBV, JCPyV and BKPyV can be associated with anal cancer, with HPV being the dominant viral cause. Although in cervical cancer, this coinfection is often observed, and it may enhance cervical oncogenic potential. These facts are particularly concerning in women living with HIV, who are more susceptible to persistent HPV infections and HPV‐related cancers. This study aimed to investigate EBV, JCPyV and BKPyV presence in HPV‐infected women living with HIV. This cross‐sectional study collected 33 cervical and 30 anal scrapings samples, as well as 26 paired samples from both sites from HPV‐positive women living with HIV. Viral detection and quantification for EBV, JCPyV and BKPyV were performed using real‐time polymerase chain reaction (qPCR), while HPV detection and genotyping utilized the Novaplex TM assay. EBV was detected in 33.3% of anal scraping and 21.2% in cervical scraping. HPV 51 and HPV 56 were most frequently detected in anal and cervical scrapings, respectively. The EBV mean viral load was higher in cervical scraping (2.27 × 10^5 copies/mL) when compared to anal scraping (1.19 × 10^5 copies/mL) in relation of JCPyV and BKPyV viral loads. Regarding coinfections, it was found that EBV presented a high coinfection rate with high‐risk HPV genotypes (hrHPV) (14.6%) with HPV 31 in both samples. This study provided valuable data about the frequency of EBV in anal and cervical HPV‐positive women. The elevated viral load of EBV in cervical scrapings may suggest a potential role in modulating the local microenvironment and warrants further investigation into the synergistic effects of EBV and HPV in anogenital and cervical carcinogenesis. Overall, the results of this study emphasize the need for further investigation into the role of these viruses in the progression of cervical lesions.
- 16 April 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (4) , e70909
Open AccessBeyond Human Papillomavirus (HPV): Detection of EBV and Polyomaviruses in Cervical and Anal Samples
Colorectal and cervical cancers represent an important public health problem worldwide, particularly in Brazil. Colorectal cancer is one of the most frequently diagnosed malignancies worldwide and the most common cancer in both men and woman in Brazil. Although cervical cancer also remains a significant public health concern in the female population due to its high incidence and mortality rates. Epstein‐Barr virus (EBV), and Polyomaviruses (JCPyV and BKPyV) are considered as oncoviruses with a prevalence of 90% in the adult population. Studies suggest that coinfection with Human papillomavirus (HPV) and EBV, JCPyV and BKPyV can be associated with anal cancer, with HPV being the dominant viral cause. Although in cervical cancer, this coinfection is often observed, and it may enhance cervical oncogenic potential. These facts are particularly concerning in women living with HIV, who are more susceptible to persistent HPV infections and HPV‐related cancers. This study aimed to investigate EBV, JCPyV and BKPyV presence in HPV‐infected women living with HIV. This cross‐sectional study collected 33 cervical and 30 anal scrapings samples, as well as 26 paired samples from both sites from HPV‐positive women living with HIV. Viral detection and quantification for EBV, JCPyV and BKPyV were performed using real‐time polymerase chain reaction (qPCR), while HPV detection and genotyping utilized the Novaplex TM assay. EBV was detected in 33.3% of anal scraping and 21.2% in cervical scraping. HPV 51 and HPV 56 were most frequently detected in anal and cervical scrapings, respectively. The EBV mean viral load was higher in cervical scraping (2.27 × 10^5 copies/mL) when compared to anal scraping (1.19 × 10^5 copies/mL) in relation of JCPyV and BKPyV viral loads. Regarding coinfections, it was found that EBV presented a high coinfection rate with high‐risk HPV genotypes (hrHPV) (14.6%) with HPV 31 in both samples. This study provided valuable data about the frequency of EBV in anal and cervical HPV‐positive women. The elevated viral load of EBV in cervical scrapings may suggest a potential role in modulating the local microenvironment and warrants further investigation into the synergistic effects of EBV and HPV in anogenital and cervical carcinogenesis. Overall, the results of this study emphasize the need for further investigation into the role of these viruses in the progression of cervical lesions.
- Open Access
- 31 October 2025
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 144, 105006
Histopathological analysis reveals mild to moderate changes in BALB/c mice after short-term administration of a microemulsion loaded with epoxy-α-lapachone
- 31 October 2025
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 144, 105006
Open AccessHistopathological analysis reveals mild to moderate changes in BALB/c mice after short-term administration of a microemulsion loaded with epoxy-α-lapachone
- 12 August 2024
- Published by Elsevier in Environmental Research
- Vol. 261, 119781
Bisphenol S exposure induces cardiac remodeling and aggravates high-fat diet-induced cardiac hypertrophy in mice
- 12 August 2024
- Published by Elsevier in Environmental Research
- Vol. 261, 119781
Bisphenol S exposure induces cardiac remodeling and aggravates high-fat diet-induced cardiac hypertrophy in mice
- Open Access
Diversity of Anal HPV and Non-HPV Sexually Transmitted Infections and Concordance with Genital Infections in HIV-Infected and HIV-Uninfected Women in the Tapajós Region, Amazon, Brazil
The aim of this study was to classify the diversity of anal HPV and non-HPV sexually transmitted infections (STIs) and compare the concordance between anal and genital infections in HIV-infected and uninfected women living in the Tapajós region, Amazon, Brazil. A cross-sectional study was performed with 112 HIV-uninfected and 41 HIV-infected nonindigenous women. Anal and cervical scrapings were collected and analyzed for HPV, Chlamydia trachomatis (CT), Neisseria gonorrheae (NG), Trichomonas vaginalis (TV), Mycoplasma genitalium (MG), and Human alphaherpesvirus 2 (HSV-2). The Kappa test evaluated the concordance between anal and genital infections. The overall prevalence of anal HPV infection was 31.3% in HIV-uninfected and 97.6% in HIV-infected women. The most frequent anal high-risk HPV (hrHPV) types were HPV18 and HPV16 in HIV-uninfected women and HPV51, HPV59, HPV31, and HPV58 in HIV-infected women. Anal HPV75 Betapapillomavirus was also identified. Anal non-HPV STIs were identified in 13.0% of all participants. The concordance analysis was fair for CT, MG, and HSV-2, almost perfect agreement for NG, moderate for HPV, and variable for the most frequent anal hrHPV types. Thus, a high prevalence of anal HPV infection with moderate and fair concordance between anal and genital HPV and non-HPV STIs was observed in our study.
Open AccessDiversity of Anal HPV and Non-HPV Sexually Transmitted Infections and Concordance with Genital Infections in HIV-Infected and HIV-Uninfected Women in the Tapajós Region, Amazon, Brazil
The aim of this study was to classify the diversity of anal HPV and non-HPV sexually transmitted infections (STIs) and compare the concordance between anal and genital infections in HIV-infected and uninfected women living in the Tapajós region, Amazon, Brazil. A cross-sectional study was performed with 112 HIV-uninfected and 41 HIV-infected nonindigenous women. Anal and cervical scrapings were collected and analyzed for HPV, Chlamydia trachomatis (CT), Neisseria gonorrheae (NG), Trichomonas vaginalis (TV), Mycoplasma genitalium (MG), and Human alphaherpesvirus 2 (HSV-2). The Kappa test evaluated the concordance between anal and genital infections. The overall prevalence of anal HPV infection was 31.3% in HIV-uninfected and 97.6% in HIV-infected women. The most frequent anal high-risk HPV (hrHPV) types were HPV18 and HPV16 in HIV-uninfected women and HPV51, HPV59, HPV31, and HPV58 in HIV-infected women. Anal HPV75 Betapapillomavirus was also identified. Anal non-HPV STIs were identified in 13.0% of all participants. The concordance analysis was fair for CT, MG, and HSV-2, almost perfect agreement for NG, moderate for HPV, and variable for the most frequent anal hrHPV types. Thus, a high prevalence of anal HPV infection with moderate and fair concordance between anal and genital HPV and non-HPV STIs was observed in our study.
- 19 January 2021
- Published by Springer Nature in Virchows Archiv
- Vol. 479 (1) , 121-131
A novel evaluation method for Ki-67 immunostaining in paraffin-embedded tissues
The Ki-67 labeling index is traditionally used to investigate tumor aggressiveness. However, no diagnostic or prognostic value has been associated to the heterogeneous pattern of nuclear positivity. The aims of this study were to develop a classification for the patterns of Ki-67-positive nuclei; to search scientific evidence for the Ki-67 expression and location throughout the cell cycle; and to develop a protocol to apply the classification of patterns of Ki-67-positive nuclei in squamous epithelium with different proliferative activities. Based on empirical observation of paraffin sections submitted to immunohistochemistry for the determination of Ki-67 labeling index and literature review about Ki-67 expression, we created a classification of the patterns of nuclear positivity (NP1, NP2, NP3, NP4, and mitosis). A semi-automatic protocol was developed to identify and quantify the Ki-67 immunostaining patterns in target tissues. Two observers evaluated 7000 nuclei twice to test the intraobserver reliability, and six evaluated 1000 nuclei to the interobserver evaluation. The results showed that the immunohistochemical patterns of Ki-67 are similar in the tumoral and non-tumoral epithelium and were classified without difficulty. There was a high intraobserver reliability (Spearman correlation coefficient > 0.9) and moderate interobserver agreement (k = 0.523). Statistical analysis showed that non-malignant epithelial specimens presented a higher number of NP1 (geographic tongue = 83.8 ± 21.8; no lesion = 107.6 ± 52.7; and mild dysplasia = 86.6 ± 25.8) when compared to carcinoma in Situ (46.8 ± 34.8) and invasive carcinoma (72.6 ± 37.9). The statistical evaluation showed significant difference (p < 0.05). Thus, we propose a new way to evaluate Ki-67, where the pattern of its expression may be associated with the dynamics of the cell cycle. Future proof of this association will validate the use of the classification for its possible impact on cancer prognosis and guidance on personalized therapy.
- 19 January 2021
- Published by Springer Nature in Virchows Archiv
- Vol. 479 (1) , 121-131
A novel evaluation method for Ki-67 immunostaining in paraffin-embedded tissues
The Ki-67 labeling index is traditionally used to investigate tumor aggressiveness. However, no diagnostic or prognostic value has been associated to the heterogeneous pattern of nuclear positivity. The aims of this study were to develop a classification for the patterns of Ki-67-positive nuclei; to search scientific evidence for the Ki-67 expression and location throughout the cell cycle; and to develop a protocol to apply the classification of patterns of Ki-67-positive nuclei in squamous epithelium with different proliferative activities. Based on empirical observation of paraffin sections submitted to immunohistochemistry for the determination of Ki-67 labeling index and literature review about Ki-67 expression, we created a classification of the patterns of nuclear positivity (NP1, NP2, NP3, NP4, and mitosis). A semi-automatic protocol was developed to identify and quantify the Ki-67 immunostaining patterns in target tissues. Two observers evaluated 7000 nuclei twice to test the intraobserver reliability, and six evaluated 1000 nuclei to the interobserver evaluation. The results showed that the immunohistochemical patterns of Ki-67 are similar in the tumoral and non-tumoral epithelium and were classified without difficulty. There was a high intraobserver reliability (Spearman correlation coefficient > 0.9) and moderate interobserver agreement (k = 0.523). Statistical analysis showed that non-malignant epithelial specimens presented a higher number of NP1 (geographic tongue = 83.8 ± 21.8; no lesion = 107.6 ± 52.7; and mild dysplasia = 86.6 ± 25.8) when compared to carcinoma in Situ (46.8 ± 34.8) and invasive carcinoma (72.6 ± 37.9). The statistical evaluation showed significant difference (p < 0.05). Thus, we propose a new way to evaluate Ki-67, where the pattern of its expression may be associated with the dynamics of the cell cycle. Future proof of this association will validate the use of the classification for its possible impact on cancer prognosis and guidance on personalized therapy.
- 1 October 2018
- Published by Elsevier in Gynecologic Oncology
- Vol. 151 (1) , 102-110
Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors
- 1 October 2018
- Published by Elsevier in Gynecologic Oncology
- Vol. 151 (1) , 102-110
Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors
- Open Access
Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene
Neurofibromatosis 1 (NF1) is one of the most common genetic disorders and is caused by mutations in the NF1 gene. NF1 gene mutational analysis presents a considerable challenge because of its large size, existence of highly homologous pseudogenes located throughout the human genome, absence of mutational hotspots, and diversity of mutations types, including deep intronic splicing mutations. We aimed to evaluate the use of hybridization capture-based next-generation sequencing to screen coding and noncoding NF1 regions. Hybridization capture-based next-generation sequencing, with genomic DNA as starting material, was used to sequence the whole NF1 gene (exons and introns) from 11 unrelated individuals and 1 relative, who all had NF1. All of them met the NF1 clinical diagnostic criteria. We showed a mutation detection rate of 91% (10 out of 11). We identified eight recurrent and two novel mutations, which were all confirmed by Sanger methodology. In the Sanger sequencing confirmation, we also included another three relatives with NF1. Splicing alterations accounted for 50% of the mutations. One of them was caused by a deep intronic mutation (c.1260 + 1604A > G). Frameshift truncation and missense mutations corresponded to 30% and 20% of the pathogenic variants, respectively. In conclusion, we show the use of a simple and fast approach to screen, at once, the entire NF1 gene (exons and introns) for different types of pathogenic variations, including the deep intronic splicing mutations.
Open AccessHybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene
Neurofibromatosis 1 (NF1) is one of the most common genetic disorders and is caused by mutations in the NF1 gene. NF1 gene mutational analysis presents a considerable challenge because of its large size, existence of highly homologous pseudogenes located throughout the human genome, absence of mutational hotspots, and diversity of mutations types, including deep intronic splicing mutations. We aimed to evaluate the use of hybridization capture-based next-generation sequencing to screen coding and noncoding NF1 regions. Hybridization capture-based next-generation sequencing, with genomic DNA as starting material, was used to sequence the whole NF1 gene (exons and introns) from 11 unrelated individuals and 1 relative, who all had NF1. All of them met the NF1 clinical diagnostic criteria. We showed a mutation detection rate of 91% (10 out of 11). We identified eight recurrent and two novel mutations, which were all confirmed by Sanger methodology. In the Sanger sequencing confirmation, we also included another three relatives with NF1. Splicing alterations accounted for 50% of the mutations. One of them was caused by a deep intronic mutation (c.1260 + 1604A > G). Frameshift truncation and missense mutations corresponded to 30% and 20% of the pathogenic variants, respectively. In conclusion, we show the use of a simple and fast approach to screen, at once, the entire NF1 gene (exons and introns) for different types of pathogenic variations, including the deep intronic splicing mutations.
- 1 September 2016
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 73 (1) , 27-33
Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients
Objective: The aim of this study was to evaluate secretory leukocyte protease inhibitor (SLPI) expression in anal biopsies from HIV-positive (HIV+) individuals, and compare that to anal intraepithelial neoplasia (AIN) diagnoses and human papillomavirus (HPV) status. Design: This is a cross-sectional study of a cohort of 54 HIV+ (31 males and 23 females) from an AIDS clinic in Rio de Janeiro, Brazil. Methods: The study material consisted of anorectal tissue biopsies obtained from HIV+ subjects, which were used to construct tissue microarray paraffin blocks for immunohistochemical analysis of SLPI expression. Biopsies were evaluated by an expert pathologist and classified as low-grade AIN1, high-grade AIN2/3, or normal squamous epithelium. In addition, DNA from the biopsies was extracted and analyzed for the presence of low- or high-risk HPV DNA. Results: Histologically, normal squamous epithelium from the anorectal region showed strong positive SLPI staining in 17/20 (85%) samples. In comparison, 9/17 (53%) dysplastic squamous epithelial samples from AIN1 patients showed strong SLPI staining, and only 5/17 (29%) samples from AIN2/3 patients exhibited strong SPLI staining, which both were significantly fewer than those from normal tissue (P = 0.005). Furthermore, there was a significantly higher proportion of samples in which oncogenic high-risk HPV genotypes were detected in low SLPI-expressing tissues than that in tissues with high SLPI expression (P = 0.040). Conclusions: Taken together these results suggest that low SLPI expression is associated with high-risk HPV infections in the development of AIN.
- 1 September 2016
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 73 (1) , 27-33
Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients
Objective: The aim of this study was to evaluate secretory leukocyte protease inhibitor (SLPI) expression in anal biopsies from HIV-positive (HIV+) individuals, and compare that to anal intraepithelial neoplasia (AIN) diagnoses and human papillomavirus (HPV) status. Design: This is a cross-sectional study of a cohort of 54 HIV+ (31 males and 23 females) from an AIDS clinic in Rio de Janeiro, Brazil. Methods: The study material consisted of anorectal tissue biopsies obtained from HIV+ subjects, which were used to construct tissue microarray paraffin blocks for immunohistochemical analysis of SLPI expression. Biopsies were evaluated by an expert pathologist and classified as low-grade AIN1, high-grade AIN2/3, or normal squamous epithelium. In addition, DNA from the biopsies was extracted and analyzed for the presence of low- or high-risk HPV DNA. Results: Histologically, normal squamous epithelium from the anorectal region showed strong positive SLPI staining in 17/20 (85%) samples. In comparison, 9/17 (53%) dysplastic squamous epithelial samples from AIN1 patients showed strong SLPI staining, and only 5/17 (29%) samples from AIN2/3 patients exhibited strong SPLI staining, which both were significantly fewer than those from normal tissue (P = 0.005). Furthermore, there was a significantly higher proportion of samples in which oncogenic high-risk HPV genotypes were detected in low SLPI-expressing tissues than that in tissues with high SLPI expression (P = 0.040). Conclusions: Taken together these results suggest that low SLPI expression is associated with high-risk HPV infections in the development of AIN.